Kirby Lattweinمشاهده پروفایل
استادیار
- Biofilm
- Staphylococcus Aureus
- Microbubble
- +۷ مورد دیگر
Kirby Lattwein serves as an Assistant Professor in the Department of Cardiology at Erasmus University Medical Center in Rotterdam, Netherlands. Their research program bridges cardiology and microbiology with a focus on biofilm development in cardiovascular infections and innovative therapeutic approaches for difficult-to-treat bacterial infections. Dr. Lattwein's primary research interests include biofilm formation mechanisms in cardiovascular contexts, particularly examining Staphylococcus aureus interactions with fibrin in the bloodstream. Their work spans multiple innovative therapeutic approaches including bacteriophage therapy for wound infections, ultrasound-mediated treatments using microbubbles to disrupt bacterial biofilms, and advanced diagnostic strategies for infective endocarditis. The research integrates principles from microbiology, cardiology, and biomedical engineering to address challenging clinical problems in cardiovascular infections. Analysis of publication trends reveals a clear progression from fundamental studies of biofilm development toward increasingly translational work with clinical applications. Early research established mechanisms of biofilm formation in cardiovascular contexts, while more recent work has developed therapeutic applications including phage therapy for burn wound infections and ultrasound-mediated disruption of bacterial biofilms. The 2022 review article on infective endocarditis has accumulated 30 citations, indicating significant impact in the field. Dr. Lattwein maintains active collaborations across multiple disciplines, working with researchers in microbiology, biomedical engineering, and clinical cardiology. Their work appears in reputable journals across these fields, demonstrating the interdisciplinary nature of their research program and its relevance to multiple scientific communities.










